Rhabdomyolysis-Associated Acute Kidney Injury

Am J Kidney Dis. 2018 Jun;71(6):A12-A14. doi: 10.1053/j.ajkd.2018.03.009.

Authors

Pasquale Esposito¹, Luca Estienne², Nicoletta Serpieri², Dario Ronchi³, Giacomo P Comi³, Maurizio Moggio⁴, Lorenzo Peverelli⁴, Stefania Bianzina⁵, Teresa Rampino²

Affiliations

¹ Department of Nephrology, Dialysis and Transplantation, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy. Electronic address: [email protected].
² Department of Nephrology, Dialysis and Transplantation, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy.
³ Neuroscience Section, Department of Pathophysiology and Transplantation, Dino Ferrari Centre, University of Milan, Neurology Unit, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
⁴ Neuromuscular and Rare Diseases Unit, BioBank of Skeletal Muscle, Peripheral Nerve, DNA and cell lines. Dino Ferrari Center, Milan, Italy.
⁵ First Department of Anesthesia and Intensive Care, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy.

PMID: 29801551
DOI: 10.1053/j.ajkd.2018.03.009

No abstract available

Publication types

Case Reports

MeSH terms

Acute Kidney Injury / etiology*
Acute Kidney Injury / physiopathology*
Acute Kidney Injury / therapy
Aged
Carnitine O-Palmitoyltransferase / deficiency*
Disease Progression
Emergency Service, Hospital
Follow-Up Studies
Hemodiafiltration / methods
Humans
Lipid Metabolism, Inborn Errors / complications*
Lipid Metabolism, Inborn Errors / diagnosis
Male
Mitochondrial Diseases / complications*
Mitochondrial Diseases / diagnosis
Muscular Diseases / complications*
Muscular Diseases / diagnosis
Rare Diseases
Rhabdomyolysis / etiology*
Rhabdomyolysis / physiopathology
Risk Assessment
Severity of Illness Index
Treatment Outcome

Substances

Carnitine O-Palmitoyltransferase

Supplementary concepts

Carnitine Palmitoyltransferase II Deficiency, Late-Onset